Research Article
Nonsteroidal Anti-Inflammatory Drugs and Risk of Melanoma
Table 2
Analgesic use and risk of first primary invasive or In situ melanoma.
| Exposure | Patients | Controls | Total | Crude OR (95% CI) | Adjusted OR (95% CI) |
| Ever use of aspirin: | | | | | | Yes | 31 | 13 | 44 | 0.854 (0.431–1.693) | 1.447 (0.442–4.736) | No | 296 | 106 | 402 | Ever use of nonaspirin NSAIDs: | | | | | | Yes | 29 | 17 | 46 | 0.584 (0.308–1.107) | 0.710 (0.234–2.024) | No | 298 | 102 | 400 | Ever use of acetaminophen: | | | | | | Yes | 6 | 3 | 9 | 0.723 (0.178–2.937) | Not assessed | No | 321 | 116 | 437 |
|
|
OR Odds ratio; CI Confidence interval; NSAIDs Nonsteroidal anti-inflammatory drugs.
|